Expansion opportunities Steri-Tek is actively expanding capacity with new and planned facilities in multiple regions (Texas, North Carolina, New York/Burlington area), indicating ongoing growth and potential demand for contract sterilization services across the East and South regions.

High capacity capability The Lewisville Texas facility features dual 10 MeV, 20 KW linear accelerators enabling high-volume, uniform dose sterilization with high uptime, suggesting Steri-Tek can handle large or time-sensitive sterilization programs for medical devices and biologics.

Regulatory readiness ISO 11137 and ISO 13485 certifications, FDA and DEA registrations, plus state medical device manufacturing licenses, position Steri-Tek as a compliant partner for regulated medical device, pharmaceutical, and biotech clients seeking validated sterilization services.

Dose mapping expertise Steri-Tek offers turnkey dose map validation and validation services for new products, enabling customers to accelerate regulatory submissions and product launches with proven sterilization validation.

Industry audience Target markets include medical devices, biotech, pharmaceutical, and food safety sectors; the combination of high capacity, regional expansion, and validation capabilities aligns with firms seeking scalable sterilization partners to support growth and supply chain resilience.